跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,182 条关于
“ITM Isotopen Technologien München”
全部
5,182
临床试验
3,620
药物
601
机构
257
资讯
704
去年
7th Annual OCT DACH Conference to Address Clinical Trial Innovation, Investment, and Diversity Challenges
10个月前
ITM Receives FDA Fast Track Designation for ITM-94 Diagnostic Agent in Clear Cell Renal Cell Carcinoma
去年
ITM Secures $262.5M Debt Financing to Support Commercial Launch of Radiopharmaceutical ITM-11 Following Positive Phase 3 Results
9个月前
Bone Metastasis Treatment Pipeline Shows Robust Development with 10+ Companies Advancing Novel Therapies
去年
German Radiopharmaceutical Biotech ITM Secures $262.5M Debt Financing to Advance Cancer Treatment Technologies
去年
ITM-11 Radiopharmaceutical Achieves Phase III Success in GEP-NETs, Outperforming Everolimus
去年
ITM and Debiopharm Initiate New Study Arm for CAIX-Targeted Theranostic in Clear Cell Renal Cell Carcinoma
去年
ITM to Present Phase 3 COMPETE Trial Data at SNMMI 2025 Meeting
去年
ITM-11 Demonstrates Superior Progression-Free Survival Compared to Everolimus in GEP-NETs
去年
ITM and Alpha-9 Oncology Partner to Supply Rare Actinium-225 for Advanced Cancer Therapies
第 1 页，共 71 页
上一页
下一页
